User menu

Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53.

Bibliographic reference Reschner, A ; Bontems, S ; Le Gac, S ; Lambermont, J ; Marcélis, Lionel ; et. al. Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53.. In: Gene Therapy, Vol. 20, p. 435-43 (2013)
Permanent URL http://hdl.handle.net/2078.2/192634
  1. Munger K., Baldwin A., Edwards K. M., Hayakawa H., Nguyen C. L., Owens M., Grace M., Huh K., Mechanisms of Human Papillomavirus-Induced Oncogenesis, 10.1128/jvi.78.21.11451-11460.2004
  2. zur Hausen Harald, Papillomaviruses and cancer: from basic studies to clinical application, 10.1038/nrc798
  3. Campion MJ, Obstet Gynecol Clin North Am, 14, 363 (1987)
  4. Syrjanen KJ, Med Biol, 65, 21 (1987)
  5. Parkin Donald Maxwell, The global health burden of infection-associated cancers in the year 2002, 10.1002/ijc.21731
  6. Cullen AP, J Virol, 65, 606 (1991)
  7. Daling Janet R., Madeleine Margaret M., Johnson Lisa Godefroy, Schwartz Stephen M., Shera Katherine A., Wurscher Michelle A., Carter Joseph J., Porter Peggy L., Galloway Denise A., McDougall James K., Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer, 10.1002/cncr.20365
  8. Lorincz AT, J Natl Cancer Inst, 79, 671 (1987)
  9. Miller Craig S., Johnstone Bryan M., Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997, 10.1067/moe.2001.115392
  10. Shillitoe E J, Papillomaviruses as targets for cancer gene therapy, 10.1038/sj.cgt.7700926
  11. Schmook T, Stockfleth E, Current treatment patterns in non-melanoma skin cancer across Europe, 10.1080/jdt.14.s3.3.10
  12. Rossi R, Giornale Italiano di Dermatologia e Venereologia, 144, 79 (2009)
  13. K�bler Alexander C., Haase Thomas, Staff Christian, Kahle Birgit, Rheinwald Markus, M�hling Joachim, Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck, 10.1002/(sici)1096-9101(1999)25:1<60::aid-lsm8>3.0.co;2-x
  14. Petrelli Nicholas J., Photodynamic Therapy in the Management of Neoplasms of the Perianal Skin, 10.1001/archsurg.1992.01420120070013
  15. Butz Karin, Ristriani Tutik, Hengstermann Arnd, Denk Claudia, Scheffner Martin, Hoppe-Seyler Felix, siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells, 10.1038/sj.onc.1206894
  16. Chi Kim N., Eisenhauer Elizabeth, Fazli Ladan, Jones Edward C., Goldenberg S. Larry, Powers Jean, Tu Dongsheng, Gleave Martin E., A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer, 10.1093/jnci/dji252
  17. Crooke Stanley, Antisense Strategies, 10.2174/1566524043360375
  18. Hong D, Lu W, Ye F, Hu Y, Xie X, Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells, 10.1038/sj.bjc.6605344
  19. Jiang Ming, Milner Jo, Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference, 10.1038/sj.onc.1205878
  20. Koivusalo R., Mialon A., Pitkanen H., Westermarck J., Hietanen S., Activation of p53 in Cervical Cancer Cells by Human Papillomavirus E6 RNA Interference Is Transient, but Can Be Sustained by Inhibiting Endogenous Nuclear Export-Dependent p53 Antagonists, 10.1158/0008-5472.can-06-2185
  21. Yamayoshi Asako, Kato Kiyoko, Suga Shin, Ichinoe Akimasa, Arima Takahiro, Matsuda Takao, Kato Hidenori, Murakami Akira, Wake Norio, Specific Apoptosis Induction in Human Papillomavirus-Positive Cervical Carcinoma Cells by Photodynamic Antisense Regulation, 10.1089/oli.2006.0047
  22. Zhang J. Bentham Science Publisher, Hua Z.C. Bentham Science Publisher, Targeted Gene Silencing by Small Interfering RNA-Based Knock-Down Technology, 10.2174/1389201043489558
  23. Elias Benjamin, Kirsch-De Mesmaeker Andrée, Photo-reduction of polyazaaromatic Ru(II) complexes by biomolecules and possible applications, 10.1016/j.ccr.2005.11.011
  24. Herman Leslie, Ghosh Sumana, Defrancq Eric, Mesmaekera Andrée Kirsch-De, Ru(II) complexes and light: molecular tools for biomolecules, 10.1002/poc.1355
  25. Dumy Pascal, Kirsch-De Mesmaeker Andr�e, Garc�a-Fresnadillo David, Lentzen Olivier, Defrancq Eric, Constant Jean-Fran�ois, Schumm Stephan, Moucheron C�cile, Determination of DNA guanine sites forming photo-adducts with Ru(II)-labeled oligonucleotides; DNA polymerase inhibition by the resulting photo-crosslinking, 10.1007/s00775-003-0502-3
  26. Lentzen O., Constant J.-F., Defrancq E., Prévost M., Schumm S., Moucheron C., Dumy P., Kirsch-De Mesmaeker A., Photocrosslinking in Ruthenium-Labelled Duplex Oligonucleotides, 10.1002/cbic.200390031
  27. Le Gac Stéphane, Rickling Stéphane, Gerbaux Pascal, Defrancq Eric, Moucheron Cécile, Kirsch-De Mesmaeker Andrée, A Photoreactive Ruthenium(II) Complex Tethered to a Guanine-Containing Oligonucleotide: A Biomolecular Tool that Behaves as a “Seppuku Molecule”, 10.1002/anie.200804503
  28. Le Gac Stéphane, Foucart Martin, Gerbaux Pascal, Defrancq Eric, Moucheron Cécile, Kirsch - De Mesmaeker Andrée, Photo-reactive RuII-oligonucleotide conjugates: influence of an intercalating ligand on the inter- and intra-strand photo-ligation processes, 10.1039/c0dt00355g
  29. Brown Stanley B, Brown Elizabeth A, Walker Ian, The present and future role of photodynamic therapy in cancer treatment, 10.1016/s1470-2045(04)01529-3
  30. DeFilippis R. A., Goodwin E. C., Wu L., DiMaio D., Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells, 10.1128/jvi.77.2.1551-1563.2003
  31. Goodwin E. C., DiMaio D., Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways, 10.1073/pnas.97.23.12513
  32. Lechner MS, EMBO J, 11, 3045 (1992)
  33. Thomas Miranda, Pim David, Banks Lawrence, The role of the E6-p53 interaction in the molecular pathogenesis of HPV, 10.1038/sj.onc.1202953
  34. Hietanen S., Lain S., Krausz E., Blattner C., Lane D. P., Activation of p53 in cervical carcinoma cells by small molecules, 10.1073/pnas.97.15.8501
  35. Koivusalo Riku, Hietanen Sakari, The cytotoxicity of chemotherapy drugs varies in cervical cancer cells depending on the p53 status, 10.4161/cbt.3.11.1340
  36. Schiller J. T., Lowy D. R., Prospects for Cervical Cancer Prevention by Human Papillomavirus Vaccination, 10.1158/0008-5472.can-06-0630
  37. Wright TC, Vaccine, 24, S3-122 (2006)
  38. Gilbert DJ, J Drugs Dermatol, 4, 161 (2005)
  39. Morton C., Campbell S., Gupta G., Keohane S., Lear J., Zaki I., Walton S., Kerrouche N., Thomas G., Soto P., , Intraindividual, right?left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study, 10.1111/j.1365-2133.2006.07470.x
  40. Piacquadio Daniel J., Chen Diana M., Farber Harold F., Fowler, Jr Joseph F., Glazer Scott D., Goodman J. John, Hruza Luciann L., Jeffes Edward W. B., Ling Mark R., Phillips Tania J., Rallis Tena M., Scher Richard K., Taylor Charles R., Weinstein Gerald David, Photodynamic Therapy With Aminolevulinic Acid Topical Solution andVisible Blue Light in the Treatment of Multiple Actinic Keratoses of the Faceand Scalp : Investigator-Blinded, Phase 3, Multicenter Trials, 10.1001/archderm.140.1.41
  41. Tschen E.H., Wong D.S., Pariser D.M., Dunlap F.E., Houlihan A., Ferdon M.B., , Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up, 10.1111/j.1365-2133.2006.07520.x
  42. Dijkstra AT, Majoie IML, van Dongen JWF, van Weelden H, van Vloten WA, Photodynamic therapy with violet light and topical delta-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma, 10.1046/j.1468-3083.2001.00333.x
  43. Morton Colin, Horn Michael, Leman Joyce, Tack Brigitte, Bedane Christophe, Tjioe Milan, Ibbotson Sally, Khemis Abdallah, Wolf Peter, Comparison of Topical Methyl Aminolevulinate Photodynamic Therapy With Cryotherapy or Fluorouracil for Treatment of Squamous Cell Carcinoma In Situ : Results of a Multicenter Randomized Trial, 10.1001/archderm.142.6.729
  44. Morton C.A., Whitehurst C., Moore J.V., Mackie R.M., Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy : RED OR GREEN LIGHT FOR PDT OF BOWEN’S DISEASE, 10.1046/j.1365-2133.2000.03773.x
  45. Basset-Seguin N, Eur J Dermatol, 18, 547 (2008)
  46. Rhodes Lesley E., de Rie Menno A., Leifsdottir Ragna, Yu Raymond C., Bachmann Ingeborg, Goulden Victoria, Wong Gavin A. E., Richard Marie-Aleth, Anstey Alex, Wolf Peter, Five-Year Follow-up of a Randomized, Prospective Trial of Topical Methyl Aminolevulinate Photodynamic Therapy vs Surgery for Nodular Basal Cell Carcinoma, 10.1001/archderm.143.9.1131
  47. Vinciullo C., Elliott T., Francis D., Gebauer K., Spelman L., Nguyen R., Weightman W., Sheridan A., Reid C., Czarnecki D., Murrell D., Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma, 10.1111/j.1365-2133.2005.06484.x
  48. Morton C.A., Brown S.B., Collins S., Ibbotson S., Jenkinson H., Kurwa H., Langmack K., Mckenna K., Moseley H., Pearse A.D., Stringer M., Taylor D.K., Wong G., Rhodes L.E., Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group, 10.1046/j.1365-2133.2002.04719.x
  49. Procianoy Fernando, Cruz Antonio A.V., Baccega Adriano, Ferraz Victor, Chahud Fernando, Aggravation of Eyelid and Conjunctival Malignancies Following Photodynamic Therapy in DeSanctis-Cacchione Syndrome : , 10.1097/01.iop.0000246600.80517.d3
  50. Wolf Peter, Rieger Edgar, Kerl Helmut, Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid, 10.1016/0190-9622(93)70002-b
  51. Morton C.A., McKenna K.E., Rhodes L.E., , Guidelines for topical photodynamic therapy: update, 10.1111/j.1365-2133.2008.08882.x
  52. Fehr Mathias K., Hornung René, Schwarz Viola A., Simeon René, Haller Urs, Wyss Pius, Photodynamic Therapy of Vulvar Intraepithelial Neoplasia III Using Topically Applied 5-Aminolevulinic Acid, 10.1006/gyno.2000.6028
  53. Fehr Mathias K., Hornung Ren�, Degen Andrea, Schwarz Viola A., Fink Daniel, Haller Urs, Wyss Pius, Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid, 10.1002/lsm.10048
  54. Abdel-Hady ES, Cancer Res, 61, 192 (2001)
  55. Ascencio M., Collinet P., Cosson M., Vinatier D., Mordon S., Intérêt et place de la thérapie photodynamique en gynécologie, 10.1016/j.gyobfe.2007.07.035
  56. Antonarakis Emmanuel S., Emadi Ashkan, Ruthenium-based chemotherapeutics: are they ready for prime time?, 10.1007/s00280-010-1293-1
  57. Schatzschneider Ulrich, Niesel Johanna, Ott Ingo, Gust Ronald, Alborzinia Hamed, Wölfl Stefan, Cellular Uptake, Cytotoxicity, and Metabolic Profiling of Human Cancer Cells Treated with Ruthenium(II) Polypyridyl Complexes [Ru(bpy)2(NN)]Cl2with NN=bpy, phen, dpq, dppz, and dppn, 10.1002/cmdc.200800039
  58. Kleinpenning Marloes M., Smits Tim, Frunt Marjolein H. A., van Erp Piet E. J., van de Kerkhof Peter C. M., Gerritsen Rianne M. J. P., Clinical and histological effects of blue light on normal skin, 10.1111/j.1600-0781.2009.00474.x
  59. Gicquel Etienne, Boisdenghien Arnaud, Defrancq Eric, Moucheron C�cile, Mesmaeker Andr�e Kirsch-De, Adduct formation by photo-induced electron transfer between photo-oxidising Ru(ii) complexes and tryptophan, 10.1039/b411686k
  60. Alvarez-Salas LM, Antivir Ther, 8, 265 (2003)
  61. Cho Cheong Weon, Poo Haryoung, Cho Young Sik, Cho Min Chul, Lee Kyung Ae, Lee Shin Je, Park Sue Nie, Kim In Ki, Jung Yong Keun, Choe Yong Kyung, Yeom Young Il, Choe In Seong, Yoon Do Young, HPV E6 antisense induces apoptosis in CaSki cells via suppression of E6 splicing, 10.1038/emm.2002.23
  62. Venturini F, Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells, 10.1093/nar/27.7.1585
  63. Márquez-Gutiérrez Miguel A., Benítez-Hess María L., DiPaolo Joseph A., Alvarez-Salas Luis M., Effect of Combined Antisense Oligodeoxynucleotides Directed against the Human Papillomavirus Type 16 on Cervical Carcinoma Cells, 10.1016/j.arcmed.2007.04.011
  64. Scheffner Martin, Werness Bruce A., Huibregtse Jon M., Levine Arnold J., Howley Peter M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, 10.1016/0092-8674(90)90409-8
  65. Putral L. N., RNA Interference against Human Papillomavirus Oncogenes in Cervical Cancer Cells Results in Increased Sensitivity to Cisplatin, 10.1124/mol.105.014191
  66. Delvenne P, Am J Pathol, 146, 589 (1995)
  67. Hubert Pascale, van den Brûle Frederic, Giannini Sandra L., Franzen-Detrooz Elizabeth, Boniver Jacques, Delvenne Philippe, Colonization of in Vitro-Formed Cervical Human Papillomavirus-Associated (Pre)Neoplastic Lesions with Dendritic Cells, 10.1016/s0002-9440(10)65324-2
  68. Merrick DT, Am J Pathol, 140, 167 (1992)
  69. Deroo Stéphanie, Defrancq Eric, Moucheron Cécile, Kirsch-De Mesmaeker Andrée, Dumy Pascal, Synthesis of an oxyamino-containing phenanthroline derivative for the efficient preparation of phenanthroline oligonucleotide oxime conjugates, 10.1016/j.tetlet.2003.09.128
  70. Deroo Stéphanie, Le Gac Stéphane, Ghosh Sumana, Villien Mathilde, Gerbaux Pascal, Defrancq Eric, Moucheron Cécile, Dumy Pascal, Kirsch-De Mesmaeker Andrée, Oligonucleotide Duplexes with Tethered Photoreactive Ruthenium(II) Complexes: Influence of the Ligands and Their Linker on the Photoinduced Electron Transfer and Crosslinking Processes of the Two Strands, 10.1002/ejic.200801083
  71. Villien Mathilde, Deroo Stéphanie, Gicquel Etienne, Defrancq Eric, Moucheron Cécile, Kirsch-De Mesmaeker Andrée, Dumy Pascal, The oxime bond formation as an efficient tool for the conjugation of ruthenium complexes to oligonucleotides and peptides, 10.1016/j.tet.2007.08.088